MOMicheal Abimbola Oladosu

Micheal Abimbola Oladosu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Micheal Abimbola Oladosu has a total of 97 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antioxidant Potential of Simulated in Vitro Gastrointestinal Digestion and Mineral Composition of Wheat and Wheat Products (Triticum spp.)

    by Oluwatomisin S. Olowoyo, Ola Salawu, Micheal A. Oladosu, Moses A. Abah, Ameh B. Agi, Adakole Okopi, Emmanuel A. Eneojo, Priscilla T. Adesanya, Temitope F. Animashaun, Olaide A. Oladosu

    A wide range of bioactive phytochemicals has been recognized to support overall health through their antioxidant potential. The current investigation seeks to evaluate the phytochemical and mineral composition of wheat and wheat products and their potential antioxidant activities after being simulated in vitro gastrointestinal digestion. Mineral analysis and phytochemical screening were carried out on the aqueous-methanolic extract and powdered samples, respectively, followed by sequential in vitro enzyme digestion. The presence of antioxidant molecules was determined based on the measurement of Total Phenol Content and Total Flavonoid Content. 1,1-diphenyl-2-picrylhydrazyl and ABTS radical scavenging ability assay, Ferric reducing antioxidant power assay, Nitric oxide and hydroxyl radical scavenging assay were carried out for antioxidant activity determination. The lipid peroxidation inhibitory activity was assessed in the brain and liver homogenates from rats induced with Iron (II) sulphate. The results indicate that raw wheat and spaghetti products are rich in important minerals like phosphorus, sodium, and potassium. Similarly, both wheat samples possess important phytochemicals, including phenol and flavonoid, both of which are decreased upon in-vitro digestion. Interestingly, our findings reveal increase in antioxidative activity upon in-vitro simulation. Finally, the results revealed that all wheat and spaghetti fractions inhibit Malondialdehyde production, suggesting the inhibition of lipid oxidation in the liver sample. However, the aqueous methanolic extracts of wheat and spaghetti, compared to their simulated in vitro digested samples, demonstrated higher inhibitory activity. The finding suggests that wheat and its processed product spaghetti offer huge benefits to individual health through its antioxidative activity.

  • Open Access

    Mathematical Modelling of Environmental Pollution Dynamics: From Contaminant Transport to Ecological Risk Prediction

    by Ezekiel Izudike Odimgbe, Micheal Abimbola Oladosu, Moses Adondua Abah, Otitololuwa Akinlolu Akinbode, Emmanuel Kayode Ajao, Olaide Ayokunmi Oladosu

    Environmental pollution is complex because contaminant transport, chemical transformation, environmental compartments, biological processes, and human activity interact. Mathematical modelling describes these processes and can predict pollutant fate, forming the basis for quantitative ecological risk assessment. This review considers mathematical methods for characterising the spatial and temporal dynamics of environmental contaminants in soil, water, sediment, and atmosphere. It focuses on differential equation modelling, advection–dispersion equations, reaction–transport modelling, compartmental modelling, stochastic modelling, and numerical simulation techniques. It critically assesses the mathematical representation of contaminant sources, movement, adsorption/desorption, degradation, bioaccumulation, and transformation. The discussion focuses on using models to generate pollutant concentration gradients and exposure pathways for ecological risk estimation and environmental management. The review also considers uncertainty and sensitivity analyses as key tools for assessing model reliability and identifying the parameters that most influence environmental outcomes. It also examines optimisation approaches for remediation planning, including source control, contaminant removal, biodegradation, and treatment allocation. The review discusses emerging AI and machine learning applications as complementary tools for parameter estimation, surrogate modelling, nonlinear prediction, and real-time environmental monitoring. The review also considers incorporating mechanistic mathematical models alongside data-driven models to improve predictions in complex, uncertain environments. The review emphasises the need for multiscale, interdisciplinary mathematical models that connect contaminant dynamics and ecological responses and inform risk based decision-making. Future research directions include coupled multi-compartment models, uncertainty-aware prediction, hybrid mechanistic–machine-learning models, and optimisation based environmental remediation strategies.

  • Open Access

    Pharmacogenomics and Personalized Drug Therapy: Advances in Genetic Variants, Drug Response Prediction, and Precision Medicine

    by Micheal Abimbola Oladosu, Moses Adondua Abah, Judith Osakpamwan Enemudo, Emmanuel C. Ugwuabonyi, Joanna Jesuseyi Adewara, Moses Sunkanmi Oladokun

    The study of individual drug response due to genetic variation, known as Pharmacogenomics (PGx), has transitioned from a research concept to become a key component of precision medicine in the clinic. New advances in genetic research have led to the identification of variants of cytochrome P450 metabolising enzymes (such as CYP2D6, CYP2C19, CYP2C9) and drug transporters (SLCO1B1), and human leukocyte antigen (HLA) genes, which account for much of the inter-individual differences in efficacy and toxicity of commonly used drug classes including antiplatelets, anticoagulants, antidepressants, statins, and chemotherapeutic drugs. This review collates recent literature (2020-2025) on three interwoven themes: (i) clinically actionable genetic variants and guidance for their use in consortia, such as the Clinical Pharmacogenetics Implementation Consortium (CPIC); (ii) the progression of drug response prediction, from rule-based algorithms through regression-based dosing models to novel machine learning and deep learning approaches incorporating multi-omics data; and (iii) the implementation of precision medicine, such as embedding clinical decision support in electronic health records (EHRs), establishing preemptive testing programmes, and the ongoing challenges of ancestral diversity, cost-effectiveness, and workforce education. We include a summary table of representative drug-gene pairs, a methodological comparison table, and an implementation efforts table, along with four figures visualising the PGx prescribing workflow, cytochrome P450 metabolizer phenotypes, an artificial intelligence approach to the prediction pipeline, and global disparities in pharmacogenomic representation. We believe the scientific and regulatory foundation for pharmacogenomic informed prescribing is developing, but translating it into routine use worldwide remains an unfinished agenda that will require coordinated clinical, informatics, and policy action.

  • Open Access

    Plant-Mediated Green Nanoparticles in Modern Drug Delivery: Advances in Synthesis, Characterization, Therapeutic Applications, and Safety Challenges

    by Ezekiel Izudike Odimgbe, Micheal Abimbola Oladosu, Moses Adondua Abah, Emmanuel.ORisewenyinmi Ajagbawa, Bashidoshi Bawa Musa, Judith Osakpamwan Enemudo

    Background: With the increasing demand for biocompatible, cost-effective, and environmentally friendly nanocarriers, plant-mediated (green) synthesis of metallic and metal-oxide nanoparticles has become a major direction in pharmaceutical research. Phytochemical synthesis uses the polyphenols, flavonoids, terpenoids, and proteins available in plant extracts as reducing and capping agents to produce nanoparticles that are less toxic and more biologically active than those produced by conventional physicochemical methods. Objective: This study aims to summarise the literature on the synthesis, characterisation, and therapeutic potential of plant mediated nanoparticles over the past five years (2020-2025), focusing on their incorporation into current drug delivery systems. Methodology: We used PubMed, ScienceDirect, Web of Science/Scopus, SpringerLink, and Google Scholar to conduct the structured narrative review. We screened articles published from January 2020 to September 2025 using combinations of keywords, including green synthesis, characterisation, phytochemicals, drug delivery, plant-mediated nanoparticles, and nanotoxicology. We included articles only if they reported a synthesis mechanism, physicochemical characterisation, or a biomedical/toxicological outcome. Findings: Plant-extracted-synthesised silver, gold, zinc oxide and iron oxide nanoparticles show good physicochemical characteristics (around 1-100 nm), which are supported by the results of UV-Vis, FTIR, and XRD, TEM/SEM and dynamic light scattering studies show antimicrobial, anticancer, antioxidant, and targeted drug-delivery activities. However, important barriers to translation remain, including batch-to-batch variability, incomplete phytochemical characterisation, and insuficient long-term toxicity data. Conclusions: Plant-mediated nanoparticles are a potential scalable alternative for next-generation drug delivery, but future applications require standard synthesis protocols and thorough safety testing.

  • Open Access

    Next-Generation Nanocarrier Systems for Targeted Drug Delivery: Advances in Lipid, Polymeric, Metal-Based, and Green Nanoparticles

    by Isioma Christian Okonta, Micheal Abimbola Oladosu, Moses Adondua Abah, Emmanuel Buchi Onyioha, Judith Osakpamwan Enemudo, Emmanuel C. Ugwuabonyi

    Nanocarrier-based drug delivery has evolved from a concept into a clinically proven platform technology, with lipid nanoparticle (LNP)- based messenger RNA vaccine delivery systems and a wide array of polymeric and metallic nanomedicines as just a few examples. The review aims to be a synthesis of recent advances in the four main classes of nanocarriers: lipid-based (liposomes, solid lipid nanoparticles, nanostructured lipid carriers, and ionizable-lipid LNPs); polymeric (poly (lactic-co-glycolic acid), chitosan, polymeric micelles and dendrimers); metal-based (gold and iron oxide nanoparticles); and green-synthesised nanoparticles (via plants, algae and microbes). For each class, the review discusses synthesis strategies, targeting mechanisms (passive enhanced permeability and retention versus active ligandmediated targeting), and representative preclinical and clinical applications. It compares these approaches with other systems to highlight trade-offs in biocompatibility, payload flexibility, targeting accuracy, and manufacturing scalability. The review discusses key translational obstacles in depth, including interpatient EPR heterogeneity, reproducibility of green-synthesis batches, and gaps in regulatory standardisation, as well as novel solutions such as stimuli-responsive design, microfluidic manufacturing, and image-guided dosing. Based on the overall picture emerging from the review, the future of targeted therapeutics depends on nanocarriers that can adapt to the tumour/tissue microenvironment, with a stronger mechanistic understanding of the tumour/tissue environment.

  • Electrocoagulation and electro-oxidation treatment of industrial wastewater from the Nigerian bottling company: Optimisation and performance evaluation

    by Sunny Chukwuemeka Eke, Henry Chijioke Uzoma, Utoh Chukwudi Promise, Okoli Chineye Mary-Cynthia, Micheal Abimbola Oladosu, Moses Adondua Abah, Olaide Ayokunmi Oladosu, Kelechi Asogwa, Timilehin Elijah Ayoola

  • Open Access

    Artificial Intelligence and the Future of Sustainable Economic Growth: Implications for Productivity, Employment, Innovation, Inequality, and Inclusive Development

    by Somto Emmanuel Ilomuanya, Micheal Abimbola Oladosu, Taiwo Olayode Mustapha, Moses Adondua Abah

    Artificial intelligence (AI) is being touted as a catchall, ‘general-purpose technology' which can transform economic growth. AI, or ‘artificial intelligence ', is emerging as a ‘catch-all' or ‘general-purpose technology' with the capacity to drive economic growth. The effects on productivity, jobs, innovation, inequality, and sustainability have been debated. The objective of this review is to bring together the peer-reviewed and working paper literature relating to the subject during the period 2020– 2025. Experimental and firm-level studies indicate significant task-level productivity improvements, particularly for less experienced workers. In macroeconomics, estimates of aggregate gains do not exceed. As for employment, so far it is not mass displacement; rather, it is task reallocation, which, as is well known, occurs with automation and leads to wage polarisation. AI is creating innovations in science and biomedicine like protein structure prediction and drug discovery, but few companies and countries can develop AI. AI can help achieve climate and Sustainable Development Goals (SDGs), but it also has significant energy, carbon, and water impacts. We believe AI-powered growth is sustainable and inclusive only if complemented by appropriate investments in skills, governance, auditing, open infrastructure, and energy-efficient computing. We recommend a policy framework and research priorities.

  • Open Access

    AI-Driven Electrocatalyst Discovery: Integrating Machine Learning, Density Functional Theory, and High-Throughput Screening for Sustainable Energy Conversion

    by Frank Onyiriuka, Obojobo Donatus Obukeajeta, Micheal Abimbola Oladosu, Moses Adondua Abah, Felix Sekayo Olagbenro, Ezekiel Izudike Odimgbe

    Efficient electrochemical processes are essential for a sustainable, low-carbon energy economy, involving hydrogen production, oxygen evolution/reduction, and carbon dioxide valorisation, all of which require high-performing electrocatalysts. Traditional catalyst development methods, which involve sequential trial-and-error synthesis and density functional theory (DFT) calculations, cannot keep pace with the combinatorial complexity of multi-metallic, single-atom, and high-entropy alloy catalysts. This review summarizes recent advances in AI-driven electrocatalyst discovery in the past five years (2020–2025) with a focus on the three pillars that have enabled this development: (1) machine learning (ML) algorithms and interpretable/explainable frameworks that extract descriptors of catalytic data that are physically meaningful; (2) the ability to couple ML with DFT using surrogate models, graph neural network interatomic potentials, and large benchmark datasets that reduce computational costs by orders of magnitude at close to DFT accuracy; and (3) high throughput screening pipelines for virtual and experimental screening, involving active learning and Bayesian optimisation, that have been applied to a diverse range of electrocatalytic reactions, including the hydrogen evolution reaction, the oxygen evolution/reduction reaction, and the carbon dioxide reduction reaction. Single-atom catalysts, perovskite oxides, and high-entropy alloys are discussed as representative examples that have helped discover new, high-performance candidates and reduced the need for one to two orders of magnitude of DFT calculations. The review also covers emerging autonomous, closed-loop ‘selfdriving’ laboratories, where robotised synthesis and characterisation are coupled with ML-driven decision-making. The review critically discusses persistent challenges in data scarcity, model interpretability and transferability across chemical spaces, and experiment-theory reproducibility, and envisions future directions such as foundation models for atomistic simulation and multimodal data fusion toward fully autonomous electrocatalyst discovery for sustainable energy conversion.

  • Open Access

    AI-Enabled Digital Twins for Smart Grids: RealTime Monitoring, Predictive Control, Cybersecurity and Future Research Directions

    by Jennifer Ikeoluwa Ade-Moomiyo, Micheal Abimbola Oladosu, Moses Adondua Abah, Ugonna Stanley Nwani, Ifechukwu Victor Muoghalu, Anyan Adebayo Anyan

    Digital twin (DT) technology combined with artificial intelligence (AI) is becoming a key enabler for resilient and self-optimising electrical power networks that are increasingly digitalised. A digital twin is a continuously updated virtual representation of a physical grid asset or network that uses real-time sensor, phasor measurement unit (PMU), and Internet of Things (IoT) data to closely mirror its physical counterpart. Digital twins become predictive, prescriptive, and self-healing decision-support systems when machine learning (ML) and deep learning (DL) algorithms are integrated into this virtual-physical feedback loop. This review aims to bring together the recent literature (2020-2025) on the field of AIpowered digital twins under four thematic areas: (i) architectural foundations and enabling technologies, (ii) real-time monitoring and state estimation, (iii) predictive control and maintenance, and (iv) cybersecurity monitoring and threat mitigation. Tables summarise enabling technologies, predictive-control case studies, and case studies of cyber-threat countermeasures reported in the literature. The review also pinpoints open research challenges such as interoperability standards, federated and privacypreserving learning, explainability of AI-driven decisions on the grid, and quantum-assisted twin computation. It suggests a research roadmap for further work. The synthesis signals that while AI-powered digital twins can tangibly reduce unplanned downtime, improve forecasting precision, and boost cyberphysical attack resilience, standardisation, data governance, and trustworthy AI remain to be addressed to enable widespread adoption.

  • Open Access

    Federated AI, Health Data Interoperability, and Digital Twins in Africa: A Framework for Privacy-Preserving Precision Healthcare in Resource-Limited Settings

    by Christianah Oluwatosin Agboola, Micheal Abimbola Oladosu, Moses Adondua Abah, Sulaimon Olajuwon Abdul, Oluwatobi Adetunji Abe, Olaide Ayokunmi Oladosu

    While Africa has a disproportionately high share of the global disease burden, it is also plagued by poor connectivity, a lack of genomic reference data, and diverse digital and network infrastructure that impede the continents shift toward precision healthcare. To work around these constraints, three converging technologies offer a way forward: federated artificial intelligence (federated learning), which allows for model training to be done collaboratively across institutions without sharing sensitive patient data; health data interoperability standards, which make it possible to exchange health information from heterogeneous electronic health record (EHR) and mobile-health systems; and digital twins, dynamically updated virtual patients or virtual population models for simulation-based health-related decisionmaking. This narrative review collates literature published from 2020–2025 on these three technologies in Africa and other resource-constrained environments, including federated-learning pilots for tuberculosis and foetal-ultrasound screening, continentwide scoping of interoperability, and early digital-twin architectures proposed for low-resource African health systems. We propose an integrated, layered structure that connects local federated-learning nodes, an interoperable semantic data layer, and a regional digital-twin simulation layer, linked by privacy preserving mechanisms and Africa-specific data-governance safeguards. The paper discusses obstacles and limitations to cross-border data transfer, such as weak institutional trust in data sharing, algorithmic bias from non-representative training sets, and unreliable connections, as well as measures being taken to overcome them. In conclusion, federated AI, interoperability, and digital twins are all promising and essential for achieving privacy preserving precision healthcare at scale in Africa.